Author： D’’Alòò Francsco Voso Maria Teresa Leone Giuseppe
Publisher： Future Medicine
ISSN： 1475-0708
Source： Therapy, Vol.2, Iss.5, 2005-09, pp. : 717-731
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome
BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. :
Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?
Acta Haematologica, Vol. 134, Iss. 1, 2015-06 ,pp. :
Monthly blood transfusions decrease after four months of azacitidine
VOX SANGUINIS, Vol. 109, Iss. 2, 2015-08 ,pp. :